US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
US Telepharmacy Market Industry Trends and Forecast to 2034: Segmented by (Setting, Service, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$4.48 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $3.00 Bn | — | — |
| 2025 (base) | $3.30 Bn | +$299.9 Mn | — |
| 2026 (forecast) | $3.63 Bn | +$329.9 Mn | +10% |
| 2027 (forecast) | $3.99 Bn | +$362.9 Mn | +21% |
| 2028 (forecast) | $4.39 Bn | +$399.2 Mn | +33.1% |
| 2029 (forecast) | $4.83 Bn | +$439.1 Mn | +46.4% |
| 2030 (forecast) | $5.31 Bn | +$483.0 Mn | +61.1% |
| 2031 (forecast) | $5.84 Bn | +$531.3 Mn | +77.2% |
| 2032 (forecast) | $6.43 Bn | +$584.4 Mn | +94.9% |
| 2033 (forecast) | $7.07 Bn | +$642.8 Mn | +114.4% |
| 2034 (forecast) | $7.78 Bn | +$707.1 Mn | +135.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $3.30 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $7.78 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Setting, service and end user (see all) |
| Key players | PipelineRx, Cardinal Health, TelePharm (Outcomes), Amazon Pharmacy, CVS Health (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Telepharmacy lets pharmacists check prescriptions and counsel patients remotely, supporting rural and hospital pharmacies.
Key segments of the telepharmacy market include setting (Retail Telepharmacy, Hospital Telepharmacy and Remote Order Entry) and service (Prescription Verification, Counselling and Medication Review).
Patient demand for care closer to home, staff shortages, lower costs than hospital stays and better remote monitoring technology are driving the telepharmacy market. Payment rules for virtual care have become more supportive.
Hospital-level care at home, chronic disease programs and virtual specialist services give the telepharmacy market strong room to grow.
Uneven reimbursement, rules on licensing across borders, poor internet in some areas and the need for strong clinical oversight hold back the telepharmacy market.
The telepharmacy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[1]
[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Licensing, quality standards and payment models from public and private payers shape how telepharmacy services are delivered and paid for in US. Government health programs and insurance coverage are key to access.
What doctors and scientists are doing in Telepharmacy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Digital Health · US
Pharmaceuticals · US
Digital Health · US
Digital Health · US
Digital Health · US
Digital Health · US